7.1 Tumor immunoassay Flashcards

1
Q

Study of antigens associated with tumors,

the tumor’s effect in the immune status, and the use of immune system to eliminate the tumor

A

Tumor immunology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Regulatory proteins that promote cell division

A

Protooncogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mutated or altered cell division resulting resulting to uncontrol

A

Oncogene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Gene that removes growth inhibitor signals when altered or mutated

A

Tumor suppressor genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Abnormal cell growths that can be benign or malignant

A

Tumor or neoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Encapsulated, movable and easily removed type of tumor without causing death

A

Benign tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A type of tumor that grows rapidly by infiltration or expansion, difficult to remove and usually caused death

A

Malignant tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Malignant tumor is encapsulated

T or F

A

F

Nonencapsulated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When malignant cells travel throguh the body and causes new foci of malignancy until body function is disrupted

A

Metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Antigen that is specific to a tumor

A

Tumor-specific-antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antigen seen in tumors cells and limited number of normal cells

A

Tumor-associated antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Potential mechanisms of de novo expression of tumor-specific antigens:

Activation of silent gene resulting to expression of new protein

T or F

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Potential mechanisms of de novo expression of tumor-specific antigens:

Point mutations that give rise to mutant peptides

T or F

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Potential mechanisms of de novo expression of tumor-specific antigens:

Alteration in the structure of proteins that does not allow exposure of previously sequestered antigens

T or F

A

F

Allows exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

May indicate aberrant expression of proteins that were expressed during
development but not expressed on normal mature cells

A

Tumor-associated antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Antigens during development which expressed in different types of tumors and in normal cells during inflammatory states

A

Oncofetal antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Low concentration of Oncofetal antigen in normal adults

T or F

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Oncofetal antigens is important in diagnosis and monitoring of therapy

T or F

A

T

19
Q

Examples of Oncofetal antigens

A

Alpha fetoprotein

Human chroionic gonadotropin

Carcinoembryonic antigen

20
Q

Secreted normally during embryonic development

a. Alpha fetoprotein
b. Human chorionic gonadotropin
c. Carcinoembryonic antigen

A

a

21
Q

Associated with pregnancy and some forms of cancers

a. Alpha fetoprotein
b. Human chorionic gonadotropin
c. Carcinoembryonic antigen

A

b

22
Q

Significantly increased in both hepatic and germ cell tumor

a. Alpha fetoprotein
b. Human chorionic gonadotropin
c. Carcinoembryonic antigen

A

a

23
Q

Greatly expressed in colonic carcinomas; also associated with lung, breast, and stomach cancers

a. Alpha fetoprotein
b. Human chorionic gonadotropin
c. Carcinoembryonic antigen

A

c

24
Q

Increased in cigarette smokers ad those with alcoholic cirrhosis

a. Alpha fetoprotein
b. Human chorionic gonadotropin
c. Carcinoembryonic antigen

A

c

25
Q

In alpha-fetoprotein, serum levels cannot served as a diagnostic marker but can be used for monitoring recurrence of metastases of primary tumors

T or F

A

T

26
Q

Decreased in Beta-HCG in non-pregnant women or in men is strongly suggestive of a tumor

T or F

A

F

Elevated beta-HCG

27
Q

Human chorionic gonadotropin is an important tumor marker for diagnosis and for monitoring therapy and recurrence

T or F

A

T

28
Q

Carcinoembryonic antigen is useful for monitoring recurrence or metastases of tumors

T or F

A

T

29
Q

Carcinoembryonic antigen is not used as a specific marker for colon cancer

T or F

A

T

30
Q

Enzyme immunoassays is the method of choice for ALL Oncofetal antigens types

T or F

A

T

31
Q

Macrophage destroys tumor cells in vivo

T or F

A

F

In vitro

32
Q

What is the CD for tumor-specific in T cells?

A

CD8(+)

33
Q

Demonstrates opsonins-mediated phagocytosis via FcyR

a. Macrophage
b. B cells
c. NK Cells
d. T cells

A

a

34
Q

Lysis of tumor cells in vitro after direct interaction to their target cell

a. Macrophage
b. B cells
c. NK Cells
d. T cells

A

c

35
Q

Releases perforin

a. Macrophage
b. B cells
c. NK Cells
d. T cells

A

c

36
Q

Antigen recognition followed by activation and differentiation

a. Macrophage
b. B cells
c. NK Cells
d. T cells

A

b

37
Q

Secretes tumor necrosis factor (TNF-alpha)

a. Macrophage
b. B cells
c. NK Cells
d. T cells

A

a

38
Q

Demostrates antibody dependent cell-mediated cytotoxicity

a. Macrophage
b. B cells
c. NK Cells
d. T cells

A

c

39
Q

NK cells are enhance by what type of cytokine?

A

Type 1 cytokine

40
Q

Antibodies are the immunological effectors from B cells

T or F

A

T

41
Q

What immunoglobulin do opsonization and ADCC?

A

IgG

42
Q

What immunoglobulin activates complement?

A

IgM

43
Q

Use for DNA/RNA molecular diagnostic?

A

FISH

Fluorescent In Situ hybrization